CrossrefInfokarte
Will Continuous Glucose Monitoring Metrics Replace Hemoglobin A1c in Assessing the Risk of Retinopathy (and Other Complications) in Patients with Type 2 Diabetes?
Clinical Diabetology · 2024
DOI: 10.5603/cd.101353 ↗Abstract
Kein Abstract verfügbar.
EUVIMED